Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial by Michael J R Desborough, Timothy J Coats, Philip M Bath, Rustam Al-Shahi Salman, Nikola Sprigg, Simon J Stanworth, Trish Hepburn, Paul M Brennan, Diane Havard, Robert A Dineen

Get full text